| The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs (NCT00002391) | Glaxo Wellcome | |
| Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome (NCT00002074) | Pfizer | |
| Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs (NCT00006290) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Peer Education to Prevent HIV Transmission Among Injection Drug Users and Their HIV Risk Contacts (NCT00038688) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Evaluate the Use of Cidofovir (an Experimental Drug) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in AIDS Patients (NCT00000945) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients (NCT00002000) | Glaxo Wellcome | |
| A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis (NCT00000698) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex (NCT00002163) | Glaxo Wellcome | |
| Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081) (NCT00000676) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Zidovudine Plus Acyclovir in HIV-Infected Patients (NCT00001010) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs (NCT00002227) | Dupont Merck | |
| A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection (NCT00002270) | University of Miami | |
| A Study to Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body (NCT00029341) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Rosiglitazone and Exercise Training: Effects on HIV-Infected People With Insulin Resistance, Hypertriglyceridemia, and Adipose Tissue Maldistribution (NCT00025753) | National Center for Research Resources (NCRR) | |
| A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection (NCT00000789) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients (NCT00001086) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC) (NCT00002170) | Agouron Pharmaceuticals | |
| A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients (NCT00002122) | Pfizer | |
| Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients (NCT00001039) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis (NCT00002316) | Alkermes, Inc. | |
| A Study of Isoprinosine in Patients With Lymph Node Disease (NCT00002297) | Newport Pharmaceuticals International | |
| ALVAC-HIV vCP1452 Alone and Combined With MN rgp120 (NCT00011037) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS (NCT00002257) | Hoffmann-La Roche | |
| Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations (NCT00002398) | Gilead Sciences | |
| Gene Therapy in HIV-Positive Patients With Non-Hodgkin's Lymphoma (NCT00002221) | Ribozyome | |
| A Comparison of Saquinavir Hard- and Soft-Gelatin Capsules in HIV-Infected Patients (NCT00002383) | Hoffmann-La Roche | |
| A Study of Two Adherence Plans to Help HIV-Positive Patients Take Their Medications Correctly (NCT00001129) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of Giving Indinavir and Nelfinavir to HIV-Infected Patients (NCT00002375) | Merck Sharp & Dohme LLC | |
| Effect of Interleukin-2 on HIV Treatment Interruption (NCT00015704) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers (NCT00000808) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants (NCT00000960) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex (ARC) (NCT00000659) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia (NCT00002386) | Merck Sharp & Dohme LLC | |
| A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss (NCT00000854) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex (NCT00000672) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients (NCT00001075) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Retrovir in the Prevention of HIV Infection in Health Care Workers Accidentally Exposed to the Virus (NCT00002287) | Glaxo Wellcome | |
| A Study of Zidovudine in HIV-Infected Patients With Kidney Problems (NCT00000685) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia (NCT00078182) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects. (NCT00002139) | Pfizer | |
| A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days (NCT00002136) | Daiichi Pharmaceuticals | |
| A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS (NCT00002034) | Hoffmann-La Roche | |
| A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants (NCT00000887) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy (NCT00002038) | Pfizer | |
| A Study on the Safety and Effectiveness of Adefovir Dipivoxil in Combination With Anti-HIV Therapy (HAART) in HIV-Positive Patients (NCT00002426) | Gilead Sciences | |
| A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease (NCT00000662) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Babies (NCT00000942) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors (NCT00001073) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy (NCT00000651) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women (NCT00044837) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Effect of Stomach Acid on Foscarnet (NCT00000964) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons (NCT00000743) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients (NCT00001070) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Computer-Assisted Adherence Program for Patients Taking Anti-HIV Drugs (NCT00051766) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides (NCT00000802) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Withdrawal of Antifungal Treatment for Histoplasmosis in Patients After Improved Immune Response to Anti-HIV Drugs (NCT00006316) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection (NCT00000790) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT) (NCT00000727) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection (NCT00000666) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Maximum Tolerated Dose Study of CI-1012 in Late-Stage HIV+ Patients (NCT00002218) | Parke-Davis | |
| A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection (NCT00000762) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected Women (NCT00000809) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood (NCT00000941) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment (NCT00002394) | Novartis | |
| A Phase I, Multicenter, Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules (NCT00001037) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related Complex (NCT00002281) | Amgen | |
| A Study of Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney Disease (NCT00002397) | Hoffmann-La Roche | |
| A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and Lamivudine (NCT00002424) | Merck Sharp & Dohme LLC | |
| The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children (NCT00001054) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Compare Two Different Anti-HIV Drug Regimens (NCT00000924) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3 (NCT00002123) | Pharmacia and Upjohn | |
| A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients (NCT00000863) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Patients Who Recently Have Been Infected With HIV (NCT00006415) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis (NCT00002040) | Pfizer | |
| Effects of BufferGel and PRO 2000/5 Gel in Men (NCT00016536) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Effectiveness of Human Antibodies in Influencing an AIDS-Like Disease in Monkeys (NCT00031109) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults (NCT00096850) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox-gp160 MN (ALVAC vCP125, HIV-1 gp160 MN) in HIV-1 Uninfected Adult Volunteers (NCT00000813) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy (NCT00000673) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of L-735,524 in HIV-Positive Children and Adolescents (NCT00002351) | Merck Sharp & Dohme LLC | |
| A Study of WF 10 IV Solution in Patients With Advanced HIV Disease (NCT00002152) | Oxo Chemie GmbH | |
| Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection (NCT00000638) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Indinavir Plus Ritonavir Plus Two NRTIs in HIV-Infected Patients Who Need Early Intervention Treatment (NCT00005118) | Merck Sharp & Dohme LLC | |
| Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis (NCT00000894) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Carotid Artery Thickness in HIV Infected and Uninfected Adults (NCT00007319) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Azithromycin in HIV-Infected Patients (NCT00002344) | Pfizer | |
| A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers (NCT00000868) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain (NCT00002160) | Neurex | |
| Promoting Safer Sex in HIV+ Homosexual and Bisexual Men Who Use Methamphetamine (NCT00291512) | University of California, San Diego | |
| Dexamethasone in Cryptococcal Meningitis (NCT00000776) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study (NCT00002080) | Pharmacia | |
| Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir) (NCT00004981) | Glaxo Wellcome | |
| Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir (NCT00002220) | Merck Sharp & Dohme LLC | |
| Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS (NCT00001059) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3 (NCT00000779) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Effects of Anti-HIV Drugs on the HIV Virus in HIV-Infected Patients (NCT00006442) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease. (NCT00000856) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Anti-HIV Activity and Safety of 3 Different Doses of Mifepristone in HIV Infected People (NCT00099645) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Identifying Emergency Room Patients Who Have Recently Been Infected With HIV (NCT00001130) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients (NCT00002236) | Pharmacia and Upjohn | |